Cargando…
ESRP1 as a prognostic factor of non‐small‐cell lung cancer is related to the EMT transcription factor of Twist
OBJECTIVE: Non‐small‐cell lung cancer (NSCLC) is one of the most common fatal cancers in the world. Although the treatment of NSCLC has been significantly improved, there is still an unmet need to identify novel targets for developing therapeutic agents and diagnostic/prognostic markers. The aim of...
Autores principales: | Cui, Jieda, Ren, Peng, Li, Yan, Ma, Yunfan, Wang, Jingdi, Lin, Chutong, Jing, Liang, Tong, Xuexia, Ma, Shaohua, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447917/ https://www.ncbi.nlm.nih.gov/pubmed/34342121 http://dx.doi.org/10.1111/1759-7714.14088 |
Ejemplares similares
-
Prognostic value of different N1 lymph node zones in pN1M0 non-small cell lung cancer: a systematic review and meta-analysis
por: Hu, Fengling, et al.
Publicado: (2021) -
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
por: Harvey, Samuel E., et al.
Publicado: (2018) -
Targeting the EMT transcription factor TWIST1 overcomes resistance to
EGFR inhibitors in EGFR-mutant non-small cell lung
cancer
por: Yochum, Zachary A., et al.
Publicado: (2018) -
The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas
por: Liu, Tieju, et al.
Publicado: (2020) -
The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis
por: Lin, Chutong, et al.
Publicado: (2021)